Cargando…

Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models

Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by deregulated hepatic lipid metabolism; however, the association between MAFLD development and mitochondrial dysfunction has yet to be confirmed. Herein, we employed high-resolution respirometry, blue native polyacrylamid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qiong-Ya, Ge, Ling-Hong, Zhang, Kun, Chen, Hai-Feng, Zhan, Xin-Xin, Yang, Yue, Dang, Qing-Lin, Zheng, Yi, Zhou, Huai-Bin, Lyu, Jian-Xin, Fang, He-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475011/ https://www.ncbi.nlm.nih.gov/pubmed/32786176 http://dx.doi.org/10.24272/j.issn.2095-8137.2020.051

Ejemplares similares

Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
por: Ramanathan, Raghu, et al.
Publicado: (2022)

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
por: Lu, Zhuo, et al.
Publicado: (2022)

Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Lu, Chuan, et al.
Publicado: (2023)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction
por: Sun, Yue, et al.
Publicado: (2020)

Weight Change across Adulthood in Relation to Non-Alcoholic Fatty Liver Disease among Non-Obese Individuals
por: Ding, Yuqing, et al.
Publicado: (2022)

Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice
por: Liu, Wen, et al.
Publicado: (2023)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Ursodeoxycholic Acid Alters Bile Acid and Fatty Acid Profiles in a Mouse Model of Diet-Induced Obesity
por: Zhang, Yunjing, et al.
Publicado: (2019)

Age-Related Decline of Male Fertility: Mitochondrial Dysfunction and the Antioxidant Interventions
por: Wang, Jing-Jing, et al.
Publicado: (2022)

ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice
por: Zhang, Quan, et al.
Publicado: (2015)

Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice
por: Mo, Juan-Fen, et al.
Publicado: (2018)

Increased Nitroxidative Stress Promotes Mitochondrial Dysfunction in Alcoholic and Nonalcoholic Fatty Liver Disease
por: Song, Byoung-Joon, et al.
Publicado: (2013)

Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease
por: Fan, Houmin, et al.
Publicado: (2021)

Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
por: Liu, Huilin, et al.
Publicado: (2018)

Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment
por: Ding, Yuping, et al.
Publicado: (2023)

Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction by Increasing Mitochondrial Biogenesis
por: Xu, Qiong, et al.
Publicado: (2014)

Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat
por: Choudhury, Mahua, et al.
Publicado: (2011)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
por: Chen, Yifei, et al.
Publicado: (2022)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Mitochondrial depletion of glutaredoxin 2 induces metabolic dysfunction-associated fatty liver disease in mice
por: Scalcon, Valeria, et al.
Publicado: (2022)

Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy
por: Dang, Si-Wen, et al.
Publicado: (2023)

Adaptation of Mitochondrial Substrate Flux in a Mouse Model of Nonalcoholic Fatty Liver Disease
por: Staňková, Pavla, et al.
Publicado: (2020)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Postprandial dysfunction in fatty liver disease
por: Grandt, Josephine, et al.
Publicado: (2023)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
por: Wang, Xiaolin, et al.
Publicado: (2022)

Effect of HBx on inflammation and mitochondrial oxidative stress in mouse hepatocytes
por: Ling, Li-Rong, et al.
Publicado: (2020)

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
por: Zhang, Xin-Lei, et al.
Publicado: (2022)

QTL-mapping in the obese Berlin Fat Mouse identifies additional candidate genes for obesity and fatty liver disease
por: Delpero, Manuel, et al.
Publicado: (2022)

GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
por: Li, Yaqiong, et al.
Publicado: (2021)

Truncating PICK1 Variant Identified in Azoospermia Affected Mitochondrial Dysfunction in Knockout Mice
por: Du, Yao-qiang, et al.
Publicado: (2023)

eIF2α links mitochondrial dysfunction to dendritic degeneration
por: Qi, Xin
Publicado: (2017)

The prevalence, comorbidities, influencing factors, and identifying factors of non-obese fatty liver disease
por: Gao, Ning, et al.
Publicado: (2022)

Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
por: Barranco-Fragoso, Beatriz, et al.
Publicado: (2022)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_safp8g9tikmi1n2ui22nlcdm41